GLP1R and obesity due to melanocortin 4 receptor deficiency: Several studies evaluating body composition and physical function in people with obesity undergoing weight-loss interventions—ranging from GLP-1 receptor agonists to bariatric surgery—have detected significant muscle-mass loss.